Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07433088

Validation of Virtual Reality Tests for the Assessment of Patients With Age-related Macular Degeneration as Clinical Endpoints

Validation of Virtual Reality Tests for the Assessment of Patients With Age-related Macular Degeneration

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Streetlab · Industry
Sex
All
Age
50 Years
Healthy volunteers
Accepted

Summary

Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in industrialized countries and affects tens of millions of people worldwide, with a rapidly increasing prevalence. It causes irreversible central vision loss and significant difficulties in daily activities, impairing patients' quality of life and independence. Conventional clinical assessments, which focus on visual acuity and retinal imaging, do not fully reflect the functional impact of the disease. Virtual reality (VR) makes it possible to create immersive, controlled environments to accurately measure functional vision and simulate real-life situations. The study proposes to develop a standardized and reproducible functional test in virtual reality that can complement conventional examinations and support clinical and industrial research.

Conditions

Interventions

TypeNameDescription
OTHERObject recognition and selection taskThe Sight Performance Object Task (SPOT) is a virtual reality (VR) based assessment designed to measure the object recognition and selection capabilities. It functional vision by replicating the real-world challenge of "finding things" under controlled environmental conditions.

Timeline

Start date
2026-04-01
Primary completion
2027-04-01
Completion
2027-04-01
First posted
2026-02-25
Last updated
2026-02-25

Source: ClinicalTrials.gov record NCT07433088. Inclusion in this directory is not an endorsement.